Substance Abuse Treatment Market By Addiction Substances 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Substance Abuse Treatment Market
Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region (Europe, North America, Others)-Forecast (2016-2021)
Report Code : HCR 0386
Updated Date: 06 September, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are aggressiveness, irritability and forgetfulness. Doctors and physicians recommend community resources for the patients willing to quit the substance abuse along with certain medications which help in controlling the cravings and manage the medical complications resulting from substance abuse. Globally growing number of people addicted to such substances and increasing awareness about such treatments are expected to be the key growth drivers during the period of study.

 Substance Abuse Treatment Market

Geographically, North America dominates the Substance Abuse Treatment market owing to the higher usage of the Cocaine and opioid by the people which results into higher demand for the drug abuse treatments due to higher awareness and spending by people on such treatments. North America was followed by Europe and Asia-Pacific as second and third largest markets for Substance Abuse Treatment market. Asia Pacific is projected to have the fastest growth, owing to growing consumption of alcohols, drugs and other such substances by the youth in the region and growing awareness about such treatments in the region and government initiatives in developing nations such as China and India in this region.

This report identifies the global Substance Abuse Treatment market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global Substance Abuse Treatment market.

This report segments the global Substance Abuse Treatment market on the basis of treatment category, addiction substance and regional market as follows:
  • Substance Abuse Treatment Market research report is classified on the basis of addiction substances. Some of the major addiction substance covered in this report are as follows: Alcohol, Drugs, Cigarettes and Coffee and Others
  • Substance Abuse Treatment Market research report is classified on the basis of treatment category. Some of the major treatments category covered in this report are as follows: alcohol, nicotine dependence therapeutics and drug abuse therapeutics
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the Substance Abuse Treatment market. Some of the major companies’ profiles in detail are as follows:
  • Teva Pharmaceutical Industries, ltd
  • GlaxoSmithKline plc
  • Alkermes plc
  • Reckitt Benckiser Pharmaceuticals, Inc
  • Pfizer, Inc
1. Substance Abuse Treatment Market – Overview
2. Executive Summary 
3. Substance Abuse Treatment Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Substance Abuse Treatment Market– Forces
   4.1. Drivers
      4.1.1. Increased awareness and financial support for mental health
   4.2. Restraints
      4.2.1. No control over the addiction
      4.2.2. Lack of willingness to seek treatment for the substance abuse
   4.3. Opportunities
      4.3.1. Recommend community resources for the patients willing to quit the abuse
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Substance Abuse Treatment Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Substance Abuse Treatment Market, By Addiction Substances
   6.1. Alcohol
   6.2. Drugs
   6.3. Inhalants
   6.4. Cigarettes
   6.5. Coffee
   6.6. Others
7. Substance Abuse Treatment Market, By Treatment Category
   7.1. Alcohol Dependence
   7.2. Nicotine Dependence Therapeutics
   7.3. Drug Abuse Therapeutics
8. Substance Abuse Treatment Market, By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America 
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Substance Abuse Treatment Market – Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. Teva Pharmaceutical Industries, ltd
   10.2. GlaxoSmithKline plc
   10.3. Alkermes plc
   10.4. Reckitt Benckiser Pharmaceuticals, Inc
   10.5. Pfizer, Inc.
   10.6. Abbot Diagnostics
   10.7. Biovail Corporation
   10.8. Elly Lilly & Co
   10.9. Jhonson & Jhonson
   10.10. Elbion NV
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports